The Oncology Institute (TOI)
(Real Time Quote from BATS)
$0.48 USD
+0.01 (1.46%)
Updated Aug 6, 2024 03:57 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TOI 0.48 +0.01(1.46%)
Will TOI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TOI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TOI
Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Lags Revenue Estimates
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates
TOI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
Other News for TOI
Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2024
Topicus.com Inc. Showcases Strong Q2 Financial Growth
The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call
Topicus.com Inc. Announces Release Date for Second Quarter Results
12 Health Care Stocks Moving In Tuesday's After-Market Session